Cognitive Therapy for Suicidal Older Men in Primary Care Settings

The recruitment status of this study is unknown because the information has not been verified recently.
Verified June 2006 by National Institute of Mental Health (NIMH).
Recruitment status was  Recruiting
Sponsor:
Information provided by:
National Institute of Mental Health (NIMH)
ClinicalTrials.gov Identifier:
NCT00149773
First received: September 6, 2005
Last updated: October 5, 2010
Last verified: June 2006
  Purpose

This study will assess the effectiveness of cognitive therapy in reducing the incidence of suicide ideation and behavior in older men in a primary care setting.


Condition Intervention Phase
Suicide, Attempted
Behavioral: Cognitive Therapy
Phase 1

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Single Blind
Primary Purpose: Treatment
Official Title: Cognitive Therapy for Suicidal Older Men in Primary Care Settings

Resource links provided by NLM:


Further study details as provided by National Institute of Mental Health (NIMH):

Primary Outcome Measures:
  • Suicidal Ideation; measured at Months 1, 3, 6, 12, 18, and 24

Secondary Outcome Measures:
  • Depression; measured at Months 1, 3, 6, 12, 18, and 24
  • Hopelessness; measured at Months 1, 3, 6, 12, 18, and 24
  • Perceived Social Support; measured at Months 1, 3, 6, 12, 18, and 24

Estimated Enrollment: 48
Study Start Date: May 2005
Detailed Description:

Older adult males have the highest suicide rate of any age group in the U.S. Over 70 percent of older suicide victims have been to their primary care physician within a month of their death, many with a depressive illness that was not detected. However, most research concerning treatments for suicide ideation and behavior has focused on adolescents and young adults. Very few treatments have been developed to reduce suicide ideation and behavior in men aged 60 and above. This study will assess the effectiveness of specialized cognitive therapy versus typical treatment in treating older men with suicide ideation.

Participants in this two-year, single-blind study will be randomly assigned to receive either cognitive therapy combined with enriched care or enriched care alone. Participants will be identified in primary care settings as having experienced suicide ideation in the past month. Cognitive therapy will be provided by Ph.D.-level therapists and will be geared specifically toward older men with suicidal tendencies. The enriched care condition will consist of the usual care that individuals receive for suicide prevention, plus assessment and referral services provided by independent evaluators and study case managers. All participants will be assessed pre-treatment to attain baseline measures of suicide ideation, hopelessness, and depression. Study visits will occur at baseline and Months 1, 3, 6, 12, 18, and 24 to assess suicide ideation. Self-report and clinician-administered measures will be used to assess participants' progress.

For information on a related study, please follow this link:

http://clinicaltrials.gov/show/NCT00218725

  Eligibility

Ages Eligible for Study:   60 Years and older
Genders Eligible for Study:   Male
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Currently experiencing death ideation or suicidal ideation (total score greater than 0 on the Scale for Suicide Ideation)
  • English-speaking
  • Lives within the area served by the research unit
  • Able to provide at least 2 verifiable contacts (typically family members)

Exclusion Criteria:

  • Requires priority treatment for an acute, unstable, or severe Axis III disorder (e.g., dementia)
  • Requires priority treatment for another debilitating problem (e.g., severe alcohol or drug dependence, mania, severe anorexia)
  • Suffers from a psychotic disorder or psychotic thought processes
  • Exhibits self-mutilating behavior without any intent to commit suicide (e.g., burning oneself with a cigarette)
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00149773

Contacts
Contact: Gregory K. Brown, PhD 215-898-4104 gregbrow@mail.med.upenn.edu

Locations
United States, Pennsylvania
Psychopathology Research Unit - University of Pennsylvania Recruiting
Philadelphia, Pennsylvania, United States, 19104
Contact: Gregory K Brown, PhD    215-898-4104    gregbrow@mail.med.upenn.edu   
Contact: Barbara Marinelli    215-898-4102    marinell@mail.med.upenn.edu   
Principal Investigator: Gregory K Brown, PhD         
Principal Investigator: Aaron T Beck, MD         
Sponsors and Collaborators
Investigators
Principal Investigator: Aaron T. Beck, MD University of Pennsylvania
Principal Investigator: Gregory K. Brown, PhD University of Pennsylvania
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00149773     History of Changes
Other Study ID Numbers: P20 MH071905-01, 802223, DSIR 83-ATP
Study First Received: September 6, 2005
Last Updated: October 5, 2010
Health Authority: United States: Federal Government

Keywords provided by National Institute of Mental Health (NIMH):
Cognitive therapy
Suicide
Older men
Death ideation
Primary care

Additional relevant MeSH terms:
Suicide
Suicide, Attempted
Self-Injurious Behavior
Behavioral Symptoms

ClinicalTrials.gov processed this record on September 16, 2014